AR119973A1 - COMPOSITIONS AND METHODS OF ANTI-CD39 ANTIBODIES - Google Patents

COMPOSITIONS AND METHODS OF ANTI-CD39 ANTIBODIES

Info

Publication number
AR119973A1
AR119973A1 ARP200102560A ARP200102560A AR119973A1 AR 119973 A1 AR119973 A1 AR 119973A1 AR P200102560 A ARP200102560 A AR P200102560A AR P200102560 A ARP200102560 A AR P200102560A AR 119973 A1 AR119973 A1 AR 119973A1
Authority
AR
Argentina
Prior art keywords
compositions
antibodies
methods
cancer
treatment
Prior art date
Application number
ARP200102560A
Other languages
Spanish (es)
Inventor
Scott Chappel
Andrew Lake
Michael Warren
Austin Dulak
Erik Devereaux
Pamela M Holland
Tauqeer Zaidi
Matthew Rausch
Bianka Prinz
Nels P Nielson
Sonia Das
Alison M Oneill
Original Assignee
Surface Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surface Oncology Inc filed Critical Surface Oncology Inc
Publication of AR119973A1 publication Critical patent/AR119973A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente proporciona composiciones de anticuerpo anti-CD39 y sus usos en el tratamiento del cáncer.The present provides anti-CD39 antibody compositions and their uses in the treatment of cancer.

ARP200102560A 2019-09-16 2020-09-15 COMPOSITIONS AND METHODS OF ANTI-CD39 ANTIBODIES AR119973A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962901153P 2019-09-16 2019-09-16

Publications (1)

Publication Number Publication Date
AR119973A1 true AR119973A1 (en) 2022-01-26

Family

ID=80782141

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200102560A AR119973A1 (en) 2019-09-16 2020-09-15 COMPOSITIONS AND METHODS OF ANTI-CD39 ANTIBODIES

Country Status (1)

Country Link
AR (1) AR119973A1 (en)

Similar Documents

Publication Publication Date Title
CO2021001912A2 (en) Anti-cd112r compositions and methods
CL2019001874A1 (en) Context-permissive isoform-specific tgfß1 inhibitors and their use.
CO2020014345A2 (en) Gucy2c-specific antibodies and their uses
CY1123977T1 (en) ANTI-PD-1 AND ANTI-LAG3 ANTIBODIES FOR THE TREATMENT OF CANCER
CO2019012353A2 (en) Formulations of anti-lag3 antibodies and coformulations of anti-lag3 antibodies and anti-pd-1 antibodies
CO2020015255A2 (en) Methods and compositions for treating cancer
CL2021000704A1 (en) Signal Regulatory Alpha Protein Antibodies and Methods of Use. (application divisional 668-2019)
PE20210287A1 (en) ANTI-CD25 FOR THE DEPLETION OF SPECIFIC TUMOR CELLS
CL2018001512A1 (en) Humanized anti-CD73 antibodies.
CL2018003407A1 (en) Anti-pd-1 anti-agreements, method to produce the same and method to use the same.
EA201791554A1 (en) BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
CO2017004516A2 (en) Humanized anti-ox40 antibodies
CO2021016765A2 (en) Heteroarylaminopyrimidine amide autophagy inhibitors and methods of using these
EA201892294A1 (en) ANTIBODIES AND COMPOSITIONS AGAINST TIM-3
CY1122456T1 (en) MONOCLONAL ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USES THEREOF FOR THE THERAPEUTIC TREATMENT OF CANCER CACHESIS AND CANCER
CO2017001191A2 (en) Drug conjugates with anti-cdh6 antibodies
AR100215A1 (en) ANTIBODY-DRUG CONJUGATES ANTI-PTK7
CY1124153T1 (en) ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
MX2020004801A (en) Bispecific fusion polypeptides and methods of use thereof.
CO2022000260A2 (en) Aminopyrimidine amide autophagy inhibitors and their methods of use
AR120147A1 (en) ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
CO2021007444A2 (en) Antiperiostin antibodies and their uses
AR119973A1 (en) COMPOSITIONS AND METHODS OF ANTI-CD39 ANTIBODIES
EA202190504A1 (en) METHODS FOR TREATMENT OF PSORIASIS
AR111715A1 (en) ANTI-SIRPa ANTIBODIES